A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors

Meredith E. Davis-Gardner, Jesse A. Weber, Jun Xie, Katja Pekrun, Eric A. Alexander, Kim L. Weisgrau, Jessica R. Furlott, Eva G. Rakasz, Mark A. Kay, Guangping Gao, Michael Farzan, Matthew R. Gardner

Open source

DOI
10.3389/fimmu.2023.1105617
Published
2023-04-21
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1105617,
  title = {A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors},
  author = {Meredith E. Davis-Gardner and Jesse A. Weber and Jun Xie and Katja Pekrun and Eric A. Alexander and Kim L. Weisgrau and Jessica R. Furlott and Eva G. Rakasz and Mark A. Kay and Guangping Gao and Michael Farzan and Matthew R. Gardner},
  year = {2023},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2023.1105617},
  url = {https://doi.org/10.3389/fimmu.2023.1105617}
}

RIS

TY  - JOUR
TI  - A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
AU  - Meredith E. Davis-Gardner
AU  - Jesse A. Weber
AU  - Jun Xie
AU  - Katja Pekrun
AU  - Eric A. Alexander
AU  - Kim L. Weisgrau
AU  - Jessica R. Furlott
AU  - Eva G. Rakasz
AU  - Mark A. Kay
AU  - Guangping Gao
AU  - Michael Farzan
AU  - Matthew R. Gardner
PY  - 2023
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2023.1105617
UR  - https://doi.org/10.3389/fimmu.2023.1105617
ER  - 

APA

Davis-Gardner, M. E., Weber, J. A., Xie, J., Pekrun, K., Alexander, E. A., Weisgrau, K. L., Furlott, J. R., Rakasz, E. G., Kay, M. A., Gao, G., Farzan, M., & Gardner, M. R. (2023). A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1105617

Source records